STUVEYAH
Live / Applied — First extension granted (statement of use) (as of 29 Oct 2025)
What this means for you
Not registered yet, but its 10 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98895049
- Mark type
- Stylized text
- Filed
- 10 Dec 2024
- Published for opposition
- 06 May 2025
- Attorney of record
- Vasily Ignatenko
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment of renal disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, Pharmaceutical preparations for the treatment of cardio-vascular diseases and disorders
Owner
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
Prosecution history
- 30 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2025 — SOU EXTENSION 1 GRANTED
- 29 Oct 2025 — SOU EXTENSION 1 FILED
- 29 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 May 2025 — PUBLISHED FOR OPPOSITION
- 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Mar 2025 — NON-FINAL ACTION E-MAILED
- 06 Mar 2025 — NON-FINAL ACTION WRITTEN